Short Interest in Alpha Teknova, Inc. (NASDAQ:TKNO) Expands By 54.3%

Alpha Teknova, Inc. (NASDAQ:TKNO) was the target of a large increase in short interest in February. As of February 15th, there was short interest totalling 964,000 shares, an increase of 54.3% from the January 31st total of 624,800 shares. Currently, 9.1% of the company’s shares are short sold. Based on an average trading volume of 278,000 shares, the days-to-cover ratio is currently 3.5 days.

Institutional Trading of Alpha Teknova

Hedge funds have recently bought and sold shares of the stock. State Street Corp boosted its holdings in Alpha Teknova by 249.3% in the 3rd quarter. State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after purchasing an additional 54,700 shares during the period. Point72 Asset Management L.P. bought a new stake in Alpha Teknova in the 3rd quarter valued at $1,483,000. Nkcfo LLC bought a new stake in Alpha Teknova in the 4th quarter valued at $501,000. Geode Capital Management LLC boosted its holdings in Alpha Teknova by 24.4% in the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after purchasing an additional 36,914 shares during the period. Finally, China Universal Asset Management Co. Ltd. bought a new position in shares of Alpha Teknova during the 4th quarter worth about $94,000. 13.81% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Craig Hallum started coverage on shares of Alpha Teknova in a report on Monday, February 10th. They set a “buy” rating and a $12.00 price objective for the company.

Alpha Teknova Stock Performance

Alpha Teknova stock traded down $0.09 during mid-day trading on Friday, reaching $6.50. The company had a trading volume of 335,710 shares, compared to its average volume of 277,189. The company has a quick ratio of 3.94, a current ratio of 4.73 and a debt-to-equity ratio of 0.12. Alpha Teknova has a 52 week low of $1.16 and a 52 week high of $10.37. The company has a 50 day moving average of $8.36 and a 200-day moving average of $6.85. The firm has a market cap of $346.50 million, a price-to-earnings ratio of -8.78 and a beta of 0.34.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.